Form 13-F position report

BIOCEPT INC

Reported by MORGAN STANLEY

BIOC CUSIP 09072V501 Manager CIK 0000895421

Reported 1,820 shares, down 7,046 (79.5%) from the prior quarter.

Reported value -82.9%; share count -79.5% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2021
Shares 1,820 Quarter-end amount reported
Reported value $6,000 Fair value at quarter end
Consecutive quarters held 6 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 35000
2021-12-31 6000
2022-03-31 4000
2022-06-30 0
2022-09-30 0
2022-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for BIOCEPT INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 Reduced 0 -6 (-100.0%) 0 $0 2023-02-14
Q3 2022 New 6 +6 (0.0%) 0 $0 2022-11-14
Q2 2022 Reduced 0 -1,900 (-100.0%) 0 $0 2022-08-15
Q1 2022 Added 1,900 +80 (4.4%) < 0.01% $4,000 2022-05-13
Q4 2021 Reduced 1,820 -7,046 (-79.5%) < 0.01% $6,000 2022-02-14
Q3 2021 Reduced 8,866 -169,059 (-95.0%) < 0.01% $35,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

42 managers reported BIOCEPT INC for Q4 2021.

Managers reporting BIOCEPT INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 655,674 -2,912 < 0.01% $2,373,000 6 qtrs
GLOBEFLEX CAPITAL L P Reduced 233,578 -87,477 0.17% $846,000 2 qtrs
BlackRock Inc Added 192,752 +1,394 < 0.01% $698,000 6 qtrs
AMERIPRISE FINANCIAL INC Added 188,449 +173,812 < 0.01% $682,000 6 qtrs
MARSHALL WACE LLP Added 156,231 +51,251 < 0.01% $566,000 2 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 130,727 0 < 0.01% $473,000 6 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 91,600 +40,800 < 0.01% $332,000 2 qtrs
JPMorgan Chase & Co Added 83,775 +68,186 < 0.01% $303,000 2 qtrs
ACADIAN ASSET MANAGEMENT LLC New 62,319 +62,319 < 0.01% $225,000 1 qtr
CITADEL ADVISORS LLC Added 55,951 +39,527 < 0.01% $203,000 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 14, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,720
Shared
0
None
100

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.